BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$4.50 USD
-0.08 (-1.75%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $4.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-0.22 | -9.70% |
Earnings Summary
For their last quarter, BioCryst Pharmaceuticals (BCRX) reported earnings of -$0.28 per share, missing the Zacks Consensus Estimate of -$0.24 per share. This reflects a negative earnings surprise of 16.67%. Look out for BCRX's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year increase of 21.43%.
Earnings History
Price & Consensus
Zacks News for BCRX
Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal
BCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services